Abstract
Lung cancer patients have an increased risk for committing suicide. But no comprehensive study about the suicide issues among non‐small‐cell lung cancer (NSCLC) patients has been published. We aimed to estimate the trend of suicide rate and identify the high‐risk group of NSCLC patients. Patients diagnosed with primary NSCLC were identified from Surveillance, Epidemiology, and End Results (SEER) database (1973‐2013). Suicide mortality rate (SMR) were calculated. Multivariable logistic regression was employed to find out independent risk factors for suicide. Among 495 889 NSCLC patients, 694 (0.14%) of them died from suicide. The suicide mortality rates have significantly decreased (before 1993: 0.21%, 1994‐2003: 0.16%, after 2004: 0.09%, P < .001). Male (OR 6.22, 95% CI: 4.96‐7.98, P < .001), white (OR 3.89, 95% CI: 2.66‐5.97, P < .001), being unmarried (OR 1.43, 95% CI: 1.22‐1.67, P < .001), the elderly (60‐74 vs <60: OR 1.24, 95% CI: 1.03‐1.50, P = .024, >75 vs <60: OR 1.31, 95% CI: 1.05‐1.63, P = .018) were independently associated with higher risk of suicide mortality. Surgery (OR: 1.44, 95% CI: 1.19‐1.73, P < .001) was also relative with higher risk of suicide. Our study observed significant decrease in suicide mortality among NSCLC patients in US over past decades. Older age, male sex, unmarried status, and surgery were risk factors of committing suicide. Clinicians should be aware of these high‐risk groups.
Keywords: non‐small cell lung carcinoma, prognosis, risk factors, SEER, suicide
Short abstract
There is significant decrease in suicide mortality among NSCLC patients in US over past decades. Older age, male sex, unmarried status, surgery were risk factors of committing suicide.
1. INTRODUCTION
Suicide is one of major causes of non‐cancer‐related death, which took up 1.4% of all deaths worldwide in 2015.1 Several studies have also demonstrated that the suicide rate of cancer patients is twice that of general population.2, 3, 4, 5, 6 Notably, when considering different anatomic cancer sites, patients diagnosed with lung cancer had a higher suicide rate than those with other cancer, with a standardized mortality ratio of 5.74.2 Factors associated with increased suicide risk among lung cancer patients were Asians, men, older, widowed, small cell lung carcinoma, metastatic, and refusing treatment.7
Lung cancer is second most common cancer, and 85% of them are non‐small cell lung carcinoma (NSCLC).8 Although several researchers have observed a high risk of suicide among lung cancer patients (being discussed as a single cancer entity), further examinations of patients with the most common subtype of lung cancer (NSCLC) are required, because of totally different distribution, treatment strategy and prognosis between subtypes.2, 7, 9 However, to our knowledge, a comprehensive study about the suicide issues among NSCLC patients has not been specifically published. Given that potential suicide prevention, knowing the trend of suicide rate and the high‐risk patient is of great importance. Therefore, we conducted this study using a large population‐based database to estimate the trend of suicide rate and identify the high‐risk group of NSCLC patients. In addition, we also performed a sub‐analysis of patients diagnosed from 2004 to 2013 to depict recent issues.
2. MATERIAL AND METHODS
National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database is an authoritative source of information on cancer incidence and survival in the United States. SEER database encompasses about 28% of United State population and collect cases diagnosed between 1973 and 2013.
We extracted data of patients diagnosed with primary NSCLC from SEER database(1973‐2013) using the SEER*Stat software (v8.3.4, Cancer Statistic Branch, NCI, Calverton), using International Classification of Disease for Oncology, Third Edition (ICD‐O‐3), morphology codes: 8012/3, 8046/3, 8070/3, 8140/3, 8240/3, 8250/3, 8560/3 and 9053/3; and site codes: C33.9, C34.0, C34.1, C34.2, C34.3, C34.8 and C34.9.10, 11 Patients with unknown follow‐up, diagnosed below 18 and recognized by autopsy and death certificate were excluded.
Patients whose cause of death variable coded as “Suicide and self‐inflicted injury” were identified. We obtained the demographic and clinicopathological data from the SEER database, including age, sex, race, marital status, year at diagnosis, state, tumor site, grade, histologic type, stage, surgery, cause of death, survival time, vital status and radiation. Patients were divided into 3 groups according to age at diagnosis (younger than 60 years, 60‐74 years, and older than 75 years). Race were sorted by white, black and others. We classified patients as married or unmarried. Year of diagnosis were separated into 3 groups (before 1993, 1994‐2003, after 2004). We classified the tumor site as upper lung, middle lung, lower lung, and bronchus/others. Grade of tumor were categorized into I/II, III/IV, and unknown groups. Surgery and radiation were both classified as performed, not performed, and unknown. Disease stage for the analysis was coded based on the variable “SEER Historic Stage A.” We give a value of 0.5 months to those who didn't survive for a full month after diagnosis, because SEER record their survival time in months.
Univariate analysis using chi‐square test was used to compare patients committed suicide with those died from other causes. Multivariable logistic regression was employed to find out independent risk factors for suicide. All statistical analyses were performed using R version 3.4.2 software (Institute for Statistics and Mathematics, Vienna, Austria; http://www.r-project.org). Statistical significance was set at two‐sided P < .05.
3. RESULTS
3.1. Patient cohort characteristics
In total, 495 889 patients diagnosed with nonsmall‐cell lung cancer were extracted. Among all patients, 694 (0.14%) of them died from suicide. Among all patients, 207 306 (41.8%) of them are female while 288 583 (58.2%) of them are male. Among those patients committed suicide, 77 (11.1%) of them are female, and 617 (88.9%) of them are male. In total, 403 288 (81.3%) of them are white, 59 005 (11.9%) of them are black, and 33 596 (6.8%) of them are unknown and other races. As for those suicided patients, 634 (91.4%) of them are white, 25 (3.6%) of them are black, and 35 (5.0%) of them are unknown or other races. In all, 138 210 (27.9%) of them were diagnosed below 60, 237 648 (47.9%) of them were diagnosed between 60 to 75, and 120 031 (24.2%) of them were diagnosed over 75.
3.2. Differences in rates of suicide mortality by decade and state
The suicide mortality rates between all 3 time intervals were significantly different (before 1993: 0.21%, 1994‐2003: 0.16%, after 2004: 0.09%, overall: 0.14%, P < .001) (Table 1). Patients from Kentucky, Louisiana, New Jersey were not recorded before 1993. When considering differences among different time intervals, California (before 1993: 0.25%, 1994‐2003: 0.18%, after 2004: 0.10%, P < .001), Michigan (before 1993: 0.19%, 1994‐2003: 0.12%, after 2004: 0.07%, P = .001), Washington (before 1993: 0.27%, 1994‐2003:0.19%, after 2004: 0.11%, P = .010) show significant drop of suicide mortality rate.
Table 1.
Suicide mortality rates by states and time of diagnosis
| State | Before 1993 | SMR (%) | 1994‐2003 | SMR (%) | After 2004 | SMR (%) | Total | SMR (%) | P |
|---|---|---|---|---|---|---|---|---|---|
| All states | 246 | 0.21 | 227 | 0.16 | 221 | 0.09 | 694 | 0.14 | <.001 |
| California | 66 | 0.25 | 92 | 0.18 | 84 | 0.10 | 242 | 0.15 | <.001 |
| Connecticut | 12 | 0.11 | 9 | 0.08 | 5 | 0.04 | 26 | 0.08 | .004 |
| Georgia | 24 | 0.28 | 31 | 0.22 | 32 | 0.11 | 87 | 0.17 | .015 |
| Hawaii | 6 | 0.14 | 6 | 0.20 | 5 | 0.12 | 17 | 0.15 | .100 |
| Iowa | 25 | 0.15 | 16 | 0.17 | 11 | 0.10 | 52 | 0.14 | <.001 |
| Kentucky | — | — | 6 | 0.09 | 15 | 0.07 | 21 | 0.08 | .058 |
| Louisiana | — | — | 5 | 0.07 | 14 | 0.09 | 19 | 0.08 | .048 |
| Michigan | 48 | 0.19 | 17 | 0.12 | 10 | 0.07 | 75 | 0.14 | <.001 |
| New Jersey | — | — | 7 | 0.06 | 16 | 0.06 | 23 | 0.06 | .068 |
| New Mexico | 10 | 0.20 | 13 | 0.37 | 9 | 0.21 | 32 | 0.25 | .017 |
| Utah | 13 | 0.42 | 6 | 0.29 | 6 | 0.22 | 25 | 0.32 | .014 |
| Washington | 42 | 0.27 | 19 | 0.19 | 14 | 0.11 | 75 | 0.20 | <.001 |
SMR, Suicide mortality rate.
3.3. Risk factors of suicide mortality in the entire cohort
Univariate analysis showed that suicide mortality was significantly higher in male patient (P < .001), white (P < .001), diagnosed between 60 and 75 (P = .034), squamous cell carcinoma (P = .006), surgery (P < .001) and without radiation therapy (P = .018) (Table 2).
Table 2.
Results of univariate analysis and multivariable logistic regression for the entire cohort
| Characteristics | Overall | Suicide | SMR (%) | P a | OR | 95% CI | P b |
|---|---|---|---|---|---|---|---|
| n | 495 889 | 694 | 0.14 | ||||
| Sex | |||||||
| Female | 207 306 | 77 | 0.04 | <.001 | 1.00 | ||
| Male | 288 583 | 617 | 0.21 | 6.22 | 4.92‐7.98 | <.001 | |
| Race | |||||||
| Black | 59 005 | 25 | 0.04 | <.001 | 1.00 | ||
| Unknown/others | 33 596 | 35 | 0.10 | 2.75 | 1.65‐4.66 | <.001 | |
| White | 403 288 | 634 | 0.16 | 3.89 | 2.66‐5.97 | <.001 | |
| Marital | |||||||
| Unmarried | 223 335 | 299 | 0.13 | .319 | 1.43 | 1.22‐1.67 | <.001 |
| Married | 272 554 | 395 | 0.14 | 1.00 | |||
| Year at diagnosis | |||||||
| 2004‐ | 236 391 | 221 | 0.09 | <.001 | 1.00 | ||
| ‐1993 | 116 202 | 246 | 0.21 | 1.83 | 1.43‐2.34 | <.001 | |
| 1994‐2003 | 143 296 | 227 | 0.16 | 1.61 | 1.34‐1.95 | <.001 | |
| Age at diagnosis | |||||||
| <60 | 138 210 | 164 | 0.12 | .034 | 1.00 | ||
| 60‐75 | 237 648 | 360 | 0.15 | 1.24 | 1.03‐1.50 | .024 | |
| >75 | 120 031 | 170 | 0.14 | 1.31 | 1.05‐1.63 | .018 | |
| Site | |||||||
| Upper | 250 535 | 347 | 0.14 | .495 | |||
| Bronchus/other | 107 101 | 144 | 0.13 | ||||
| Middle | 20 688 | 24 | 0.12 | ||||
| Lower | 117 565 | 179 | 0.15 | ||||
| Grade | |||||||
| I/II | 100 566 | 144 | 0.14 | .175 | |||
| III/IV | 178 591 | 270 | 0.15 | ||||
| Unknown | 216 732 | 280 | 0.13 | ||||
| Histology | |||||||
| BAC | 16 275 | 19 | 0.12 | .006 | 1.00 | ||
| LCC | 33 119 | 48 | 0.14 | 1.12 | 0.66‐1.96 | .679 | |
| Others | 70 826 | 71 | 0.10 | 1.18 | 0.72‐2.03 | .533 | |
| S | 149 388 | 245 | 0.16 | 1.21 | 0.77‐2.01 | .431 | |
| AC | 218 088 | 296 | 0.14 | 1.35 | 0.87‐2.24 | .206 | |
| ASC | 8193 | 15 | 0.18 | 1.45 | 0.72‐2.85 | .286 | |
| Stage | |||||||
| Distant | 224 941 | 246 | 0.11 | <.001 | 1.00 | ||
| Localized | 73 293 | 111 | 0.15 | 1.15 | 0.89‐1.48 | .284 | |
| Regional | 109 710 | 149 | 0.14 | 1.05 | 0.84‐1.30 | .684 | |
| Unstaged | 87 945 | 188 | 0.21 | 1.17 | 0.91‐1.52 | .219 | |
| Surgery | |||||||
| No | 364 393 | 444 | 0.12 | <.001 | 1.00 | ||
| Unknown | 1081 | 1 | 0.09 | 0.78 | 0.04‐3.45 | .801 | |
| Yes | 130 415 | 249 | 0.19 | 1.44 | 1.19‐1.73 | <.001 | |
| Months | |||||||
| ≥6 years | 46 144 | 68 | 0.15 | .762 | |||
| 1 year | 310 902 | 436 | 0.14 | ||||
| 2 years | 74 528 | 111 | 0.15 | ||||
| 3 years | 33 462 | 38 | 0.11 | ||||
| 4 years | 18 465 | 26 | 0.14 | ||||
| 5 years | 12 388 | 15 | 0.12 | ||||
| Radiation | |||||||
| No | 265 814 | 397 | 0.15 | .018 | 1.00 | ||
| Unknown | 2932 | 8 | 0.27 | 1.66 | 0.75‐3.13 | .158 | |
| Yes | 227 143 | 289 | 0.13 | 0.88 | 0.74‐1.03 | .109 | |
AC, Adenocarcinoma; ASC, Adenosquamous carcinoma; BAC, Bronchioloalveolar; CI, confidence interval; LCC, Large cell carcinoma; S, Squamous; SMR, Suicide mortality rate.
P value on univariate analysis.
P value on logistic regression.
Multivariate logistic regression was then performed including factors significant on univariate analysis. In terms of demographic factors, sex (male vs female: OR 6.22, 95% CI : 4.96‐7.98, P < .001), race (white vs black: OR 3.89, 95% CI: 2.66‐5.97, P < .001, unknown/others vs black: OR 2.75, 95%CI: 1.65‐4.66, P < .001), marital status (unmarried vs married: OR 1.43, 95% CI: 1.22‐1.67, P < .001), year at diagnosis (‐1993 vs 2004+: OR 1.83, 95% CI: 1.43‐2.34, P < .001,1994‐2003 vs 2004+: OR 1.61, 95% CI: 1.34‐1.95, P < .001), age at diagnosis (60‐74 vs <60: OR 1.24, 95% CI: 1.03‐1.50, P = .022, >75 vs <60: OR 1.32, 95% CI: 1.06‐1.64, P = .014) were independently associated with higher risk of suicide mortality. As for clinical factors, surgery (Yes vs No: OR: 1.44, 95% CI: 1.19‐1.73, P < .001) was relative to higher risk of suicide (Table 2).
3.4. Sub‐analysis of patients diagnosed from 2004 to 2013
This subgroup of patients can better represent the demographic and clinicopathological character of recent patients. So we do the sub‐analysis of patients diagnosed from 2004 to 2013.
Univariate analysis displayed that higher suicide mortality rate was associated with male patients (P < .001), white patients (P < .001), and patients didn't have radiation therapy (P = .115). Concerning the time after diagnosis, the highest suicide mortality rate was found to be the first year after diagnosis (P = .008).
Multivariate logistic regression was operated considering factors significant on univariate analysis. In respect of demographic factors, sex (male vs female: OR 7.12, 95% CI: 4.77‐11.12, P < .001), race (white vs black: OR 4.76, 95% CI: 2.41‐11.23, P < .001, unknown/others vs black: OR 2.46, 95% CI: 0.94‐6.82, P = .069), marital status (unmarried vs married: OR 1.41, 95% CI:1.08‐1.85, P = .012) were independently correlated to higher risk of suicide mortality. As for clinical factors, radiation (Yes vs No: OR:0.74, 95% CI: 0.55‐0.99, P = .046) were relative to higher risk of suicide. Finally, time elapsed from cancer diagnosis was also relative with higher rate of suicide mortality (P = .008), with the first year of diagnosis taking the highest rate (OR 4.79, 95% CI: 1.93‐15.97, P = .003), followed by the second year (OR 4.31, 95% CI: 1.68‐14.60, P = .007) (Table 3).
Table 3.
Results of univariate analysis and multivariable logistic regression for patients diagnosed 2004‐2013
| Characteristics | Overall | Suicide | SMR (%) | P a | OR | 95% CI | P b |
|---|---|---|---|---|---|---|---|
| n | 236 391 | 221 | 0.09 | ||||
| Sex | |||||||
| Male | 128 081 | 196 | 0.15 | <.001 | 7.12 | 4.77‐11.12 | <.001 |
| Female | 108 310 | 25 | 0.02 | 1.00 | |||
| Race (%) | |||||||
| Black | 28 908 | 7 | 0.02 | <.001 | 1.00 | ||
| Unknown/others | 18 072 | 10 | 0.06 | 2.46 | 0.94‐6.82 | .069 | |
| White | 189 411 | 204 | 0.11 | 4.76 | 2.41‐11.23 | <.001 | |
| Marital | |||||||
| Unmarried | 115 326 | 109 | 0.09 | .927 | 1.41 | 1.08‐1.85 | .012 |
| Married | 121 065 | 112 | 0.09 | 1.00 | |||
| Age at diagnosis | |||||||
| <60 | 61 248 | 48 | 0.08 | .221 | 1.00 | ||
| 60‐75 | 109 508 | 102 | 0.09 | 1.08 | 0.77‐1.54 | .676 | |
| >75 | 65 635 | 71 | 0.11 | 1.22 | 0.84‐1.79 | .295 | |
| Site | |||||||
| Upper | 121 665 | 108 | 0.09 | .328 | 1.00 | ||
| Bronchus/other | 45 091 | 39 | 0.09 | 0.92 | 0.62‐1.33 | .66 | |
| Middle | 10 070 | 7 | 0.07 | 0.84 | 0.35‐1.67 | .653 | |
| Lower | 59 565 | 67 | 0.11 | 1.24 | 0.91‐1.68 | .163 | |
| Grade | |||||||
| I/II | 50 487 | 41 | 0.08 | .468 | 1.00 | ||
| III/IV | 72 850 | 75 | 0.10 | 1.22 | 0.83‐1.82 | .316 | |
| Unknown | 113 054 | 105 | 0.09 | 1.22 | 0.82‐1.83 | .338 | |
| Histology | |||||||
| BAC | 5805 | 1 | 0.02 | .292 | |||
| LCC | 6269 | 6 | 0.10 | ||||
| Others | 49 618 | 43 | 0.09 | ||||
| S | 61 110 | 58 | 0.09 | ||||
| AC | 110 006 | 107 | 0.10 | ||||
| ASC | 3583 | 6 | 0.17 | ||||
| Stage | |||||||
| Distant | 132 310 | 122 | 0.09 | .977 | 1.00 | ||
| Localized | 41 332 | 40 | 0.10 | 1.24 | 0.8‐1.89 | .321 | |
| Regional | 56 549 | 54 | 0.10 | 1.10 | 0.76‐1.56 | .608 | |
| Unstaged | 6200 | 5 | 0.08 | 0.86 | 0.3‐1.92 | .751 | |
| Surgery | |||||||
| No | 184 415 | 170 | 0.09 | .761 | 1.00 | ||
| Unknown | 560 | 1 | 0.18 | 2.06 | 0.12‐9.27 | .475 | |
| Yes | 51 416 | 50 | 0.10 | 1.34 | 0.88‐2.04 | .168 | |
| Months | |||||||
| ≥6 years | 15 970 | 4 | 0.03 | .008 | 1.00 | ||
| 1 year | 147 889 | 159 | 0.11 | 4.79 | 1.93‐15.97 | .003 | |
| 2 years | 37 135 | 35 | 0.09 | 4.31 | 1.68‐14.6 | .007 | |
| 3 years | 18 001 | 13 | 0.07 | 3.24 | 1.14‐11.58 | .041 | |
| 4 years | 10 353 | 8 | 0.08 | 3.32 | 1.04‐12.46 | .051 | |
| 5 years | 7043 | 2 | 0.03 | 1.18 | 0.16‐6.06 | .848 | |
| Radiation | |||||||
| No | 136 621 | 143 | 0.10 | .115 | 1.00 | ||
| Unknown | 1329 | 1 | 0.08 | 0.63 | 0.04‐2.83 | .65 | |
| Yes | 98 441 | 77 | 0.08 | 0.74 | 0.55‐0.99 | .046 | |
AC: Adenocarcinoma; ASC: Adenosquamous carcinoma; BAC: Bronchioloalveolar; CI: confidence interval; LCC: Large cell carcinoma; S: Squamous; SMR: Suicide mortality rate.
P value on univariate analysis.
P value on logistic regression.
4. DISCUSSION
Our study observed significant improvement in suicide prevention among NSCLC patients in US over past decades. Urban et al9 found that suicide has not changed significantly decreased in lung cancer over time. However, in contrast to rising suicide rate of US general population, the suicide mortality rate of NSCLC patients has decreased considerably over past decades, which is consistent with previous study about suicide trend among cancer patients.12, 13, 14 This result may be associated with relatively better prognosis of NSCLC, because of early screening test for lung cancer and significant advances in treatment, such as chemotherapy and targeted therapy.15, 16, 17
Demographic characteristics associated with an increased rate of suicide in the NSCLC patients, such as older age, male sex, race were similar to those in general population.18 Earlier research showed that older people tend to commit complete suicide among general population.19, 20 Older patients with cancer are also high‐risk group, which is consistent with our research.21, 22, 23 Older patients usually encountered with greater disease burden, and social psychological pressure. Higher suicide rate of older NSCLC patients may be related to pressure and depression.20 Another possible reason is that, they hold the rational will of ending their life at the right time.24 Male sex is a risk factor of suicide in NSCLC patients, and it is accordant with trends in general population and those with other cancer.2, 25 Although depression seemed to be higher in female patients with NSCLC, male patients are more likely to succeed in ending their own life.26, 27 However, the incidence of female suicidal behavior in NSCLC patients may be underrepresented, because failed suicide attempts were not recorded in the SEER database.22 Race has a significant impact on suicidal ideation. The risk of dying from suicide was more than double for the white NSCLC patients than for the black patients.28 The reason is for higher suicide rate in white patients with NSCLC is still unknown, and hopelessness in those patients is likely to associate with suicidal behavior.29 In addition, unmarried NSCLC patients are easier exposed to suicide attempts. Married patients have a greater socioeconomic status than unmarried.30, 31 Many cancer research studies have reported a poor prognosis in unmarried patients.32, 33, 34
Interestingly, characteristics of NSCLC seems to be not relevant to suicide of patients, which is controversial with former analysis.9 In patients diagnosed between 1973 and 2013, clinical characteristics such as primary site, histologic type, historic stage have no significant influence on suicide. The same as those diagnosed recently. A possible reason is that multiple primary tumor may interfere with the result. In our study, patients with multiple primary tumor were excluded to prevent interference of other tumors. Another possible reason is that the prognosis of patients with advanced NSCLC is poor, they may die from the disease itself rather than other causes. Patients diagnosed between 1973 and 2013 who undergo treatment like surgery are more likely to suicide. This is also different from previous research.9 It can be explained by debility and loss of autonomy brought by the curative surgery toward NSCLC.35
When considering patients diagnosed between 1973 and 2013, Suicide mortality rate (SMR) is not significantly associated with time after diagnosed. But SMR is observed to be higher within the first year of NSCLC diagnosis among patients diagnosed between 2004 and 2013. It has been reported that cancer patients were at high risk of suicide within the first year of diagnosis and associated demographic and clinical factors were analyzed.36 The different result can be possibly explained by the improvement of life quality of long‐term survivor of NSCLC patients, and the major reason for suicidal behavior of recent NSCLC patients is possibly shock of cancer diagnosis.37, 38
While the demographic risk factors of cancer‐related suicide are focused on, psychological and social risk factors are frequently missed. Suicide is a complicated phenomenon that biological, psychological and social risk factors would interact and influence on it. Cancer diagnosis may lead to demoralization of NSCLC patients, such as hopelessness and helplessness, which can lead to suicidal ideation.39 Poor consequences of cancer treatment may bring physical and mental pain to NSCLC patients.40 It has been reported that cancer patients with low socioeconomic status and family support are more likely to suicide.41 The National Comprehensive Cancer Network provides a distress management guideline that recommends screening all patients for distress.42 Our findings may assist oncologists to effectively identify those NSCLC patients at higher risk of suicide, specifically for older, white, unmarried male patients with surgery. For those NSCLC patients with high risk of suicide, we should pay more attention, because appropriate psychosocial interventions have a positive impact on quality of life.43 To reduce cancer‐related suicide, patients’ understanding of cancer diagnosis and treatment options should be ensured.44 Besides, promoting family communication combine with encouraging self‐determination and participation in treatment can mitigate social risk of suicide.44, 45
There are some limitations in our study. Suicide is a complicated phenomenon affected by factors such as economic level and education level. These factors are not included in SEER database. Additionally, SEER database only contains data of US patients, so our study is limited to US patients, and research over the world is still needed. Moreover, details of treatment to NSCLC were not taken in, and we only know whether patients have undergone surgery and radiation or not. Details of treatment such as the time after surgery and chemotherapy may be associated with suicide of cancer patient.3 Furthermore, our study can't obtain suicide attempts data of NSCLC patients, and patients potential to suicide were likely to be underestimated.
5. CONCLUSIONS
In summary, our study observed a significant decrease in suicide mortality among NSCLC patients in US over past decades. Older age, male sex, unmarried status, and surgery were risk factors of committing suicide. Grade, stage, histologic type and primary site of NSCLC appear not relate to suicide. It can help clinicians identified these NSCLC patients for better support and suicide prevention. Further studies are still needed.
CONFLICT OF INTEREST
All of the authors have no conflicts of interested to declare.
ACKNOWLEDGMENTS
The authors acknowledge the efforts of the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in providing high quality open resources for researchers. The authors would like to thank editors and the anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper.
Zhou H, Xian W, Zhang Y, et al. Trends in incidence and associated risk factors of suicide mortality in patients with non‐small cell lung cancer. Cancer Med. 2018;7:4146–4155. 10.1002/cam4.1656
Funding information
This work was supported by the National Key R&D Program of China (2016YFC0905500).
Zhou, Xian, and Zhang contributed equally to this work and should be regarded as co‐first authors.
REFERENCES
- 1. Suicide data. Mental Health. World Health Organization. http://www.who.int/mental_health/prevention/suicide/suicideprevent/en/. Accessed January 2018.
- 2. Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of suicide in persons with cancer. J Clin Oncol. 2008;26:4731‐4738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Matsumoto Y, Shimizu K, Kinoshita H, Shimizu C, Uchitomi Y. Suicide associated with corticosteroid use during chemotherapy: case report. Jpn J Clin Oncol. 2010;40:174‐176. [DOI] [PubMed] [Google Scholar]
- 4. Wang S‐M, Chou Y‐C, Yeh M‐Y, Chen C‐H, Tzeng W‐C. Factors associated with quality of life after attempted suicide: a cross‐sectional study. J Clin Nurs. 2013;22:2150‐2159. [DOI] [PubMed] [Google Scholar]
- 5. Balcı Şengül MC, Kaya V, Şen CA, Kaya K. Association between suicidal ideation and behavior, and depression, anxiety, and perceived social support in cancer patients. Med Sci Monit. 2014;20:329‐336. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Nikendei C, Terhoeven V, Ehrenthal JC, et al. Depression profile in cancer patients and patients without a chronic somatic disease. Psychooncology. 2018;27:83‐90. [DOI] [PubMed] [Google Scholar]
- 7. Rahouma M, Kamel M, Nasar A, et al. Lung cancer patients have the highest malignancy‐associated suicide rate in USA: a population based analysis. C94. Psychosocial Impacts on Respiratory Health and Critical Illness: American Thoracic Society, 2017:A6730. [DOI] [PMC free article] [PubMed]
- 8. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non‐small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008;83:584‐594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Urban D, Rao A, Bressel M, Neiger D, Solomon B, Mileshkin L. Suicide in lung cancer: who is at risk? Chest. 2013;144:1245‐1252. [DOI] [PubMed] [Google Scholar]
- 10. National Cancer Institute . Surveillance, Epidemiology, and End Results Program. SEER*Stat software version 8.3.4, 2017. http://www.seer.cancer.gov/seerstat. Accessed October 28, 2017.
- 11. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence ‐ SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2015 Sub (1973‐2013 varying) ‐ Linked To County Attributes ‐ Total U.S., 1969‐2014 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2016, based on the November 2015 submission. https://seer.cancer.gov/data/. Accessed October 28, 2017.
- 12. Hem E, Loge JH, Haldorsen T, Ekeberg Ø. Suicide risk in cancer patients from 1960 to 1999. J Clin Oncol. 2004;22:4209‐4216. [DOI] [PubMed] [Google Scholar]
- 13. Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366:1310‐1318. [DOI] [PubMed] [Google Scholar]
- 14. McCarthy M. Suicide rates rise sharply in the US, figures show. BMJ. 2016;353:i2355. [DOI] [PubMed] [Google Scholar]
- 15. Natukula K, Jamil K, Pingali UR, Suresh Attili VS, Naidu Madireddy UR. Survival analysis in advanced non small cell lung cancer treated with platinum based chemotherapy in combination with paclitaxel, gemcitabine and etoposide. Asian Pac J Cancer Prev. 2013;14:4661‐4666. [DOI] [PubMed] [Google Scholar]
- 16. Ulivi P, Zoli W, Capelli L, Chiadini E, Calistri D, Amadori D. Target therapy in NSCLC patients: relevant clinical agents and tumour molecular characterisation. Mol Clin Oncol. 2013;1:575‐581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Aarts MJ, van den Borne BE, Biesma B, Kloover JS, Aerts JG, Lemmens VEPP. Improvement in population‐based survival of stage IV NSCLC due to increased use of chemotherapy. Int J Cancer. 2015;136:E387‐E395. [DOI] [PubMed] [Google Scholar]
- 18. Spicer RS, Miller TR. Suicide acts in 8 states: incidence and case fatality rates by demographics and method. Am J Public Health. 2000;90:1885‐1891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Beautrais AL. A case control study of suicide and attempted suicide in older adults. Suicide Life Threat Behav. 2002;32:1‐9. [DOI] [PubMed] [Google Scholar]
- 20. O'Connell H. Recent developments: suicide in older people. BMJ. 2004;329:895‐899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Turaga KK, Malafa MP, Jacobsen PB, Schell MJ, Sarr MG. Suicide in patients with pancreatic cancer. Cancer. 2011;117:642‐647. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Kam D, Salib A, Gorgy G, et al. Incidence of suicide in patients with head and neck cancer. JAMA Otolaryngol Head Neck Surg. 2015;141:1075‐1081. [DOI] [PubMed] [Google Scholar]
- 23. Klaassen Z, Jen RP, DiBianco JM, et al. Factors associated with suicide in patients with genitourinary malignancies. Cancer. 2015;121:1864‐1872. [DOI] [PubMed] [Google Scholar]
- 24. Ruckenbauer G, Yazdani F, Ravaglia G. Suicide in old age: illness or autonomous decision of the will? Arch Gerontol Geriatr. 2007;44:355‐358. [DOI] [PubMed] [Google Scholar]
- 25. Kendal W. Suicide and cancer: a gender‐comparative study. Ann Oncol. 2006;18:381‐387. [DOI] [PubMed] [Google Scholar]
- 26. Nock MK, Borges G, Bromet EJ, Cha CB, Kessler RC, Lee S. Suicide and suicidal behavior. Epidemiol Rev. 2008;30:133‐154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Akechi T, Okamura H, Okuyama T, Furukawa TA, Nishiwaki Y, Uchitomi Y. Psychosocial factors and survival after diagnosis of inoperable non‐small cell lung cancer. Psychooncology. 2009;18:23‐29. [DOI] [PubMed] [Google Scholar]
- 28. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. Natl Vital Stat Rep. 2016;64:1‐119. [PubMed] [Google Scholar]
- 29. Hirsch JK, Visser PL, Chang EC, Jeglic EL. Race and ethnic differences in hope and hopelessness as moderators of the association between depressive symptoms and suicidal behavior. J Am Coll Health. 2012;60:115‐125. [DOI] [PubMed] [Google Scholar]
- 30. Woods LM, Rachet B, Coleman MP. Origins of socio‐economic inequalities in cancer survival: a review. Ann Oncol. 2006;17:5‐19. [DOI] [PubMed] [Google Scholar]
- 31. Zhou H, Zhang Y, Song Y, et al. Marital status is an independent prognostic factor for pancreatic neuroendocrine tumors patients: an analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Clin Res Hepatol Gastroenterol. 2017;41:476‐486. [DOI] [PubMed] [Google Scholar]
- 32. Aizer AA, Chen M‐H, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31:3869‐3876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Inverso G, Mahal BA, Aizer AA, Donoff RB, Chau NG, Haddad RI. Marital status and head and neck cancer outcomes. Cancer. 2015;121:1273‐1278. [DOI] [PubMed] [Google Scholar]
- 34. Zhou H, Zhang Y, Qiu Z, et al. Nomogram predicting cause‐specific mortality in patients with surgically resected stage I non‐small cell lung cancer: a competing risk analysis. Clin Lung Cancer. 2017;19:e195‐e203. [DOI] [PubMed] [Google Scholar]
- 35. Jayakrishnan TT, Sekigami Y, Rajeev R, Gamblin TC, Turaga KK. Morbidity of curative cancer surgery and suicide risk. Psychooncology. 2017;26:1792‐1798. [DOI] [PubMed] [Google Scholar]
- 36. Ahn MH, Park S, Lee HB, et al. Suicide in cancer patients within the first year of diagnosis. Psychooncology. 2015;24:601‐607. [DOI] [PubMed] [Google Scholar]
- 37. Molina JR, Adjei AA, Jett JR. Advances in chemotherapy of non‐small cell lung cancer. Chest. 2006;130:1211‐1219. [DOI] [PubMed] [Google Scholar]
- 38. Kobayashi T, Kato S, Takeuchi M. Considering patients’ mental capacity when giving them bad news may help their well‐being: a case of suicide attempt after being informed of lung cancer diagnosis. Case Rep Psychiatry. 2014;2014:645769. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Kissane DW. The contribution of demoralization to end of life decisionmaking. Hastings Cent Rep. 2004;34:21‐31. [PubMed] [Google Scholar]
- 40. Yamada M, Matsumura C, Jimaru Y, Ueno R, Takahashi K, Yano Y. Effect of continuous pharmacist interventions on pain control and side effect management in outpatients with cancer receiving opioid treatments. Biol Pharm Bull. 2018;41:858‐863. [DOI] [PubMed] [Google Scholar]
- 41. Choi J, Lee M, Ki M, et al. Risk factors for feelings of sadness and suicide attempts among cancer survivors in South Korea: findings from nationwide cross‐sectional study (KNHANES IV‐VI). BMJ Open. 2017;7:e016130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. National Comprehensive Cancer N . Distress management. Clinical practice guidelines. J Natl Compr Canc Netw. 2003;1:344‐374. [DOI] [PubMed] [Google Scholar]
- 43. Rehse B, Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns. 2003;50:179‐186. [DOI] [PubMed] [Google Scholar]
- 44. Banyasz A, Wells‐Di Gregorio SM. Cancer‐related suicide: a biopsychosocial‐existential approach to risk management. Psychooncology. 2018;1‐4. [DOI] [PubMed] [Google Scholar]
- 45. Kaliampos A, Roussi P. Quality of partner support moderates positive affect in patients with cancer. Psychooncology. 2018;27:1298‐1304. [DOI] [PubMed] [Google Scholar]